M-084
Modafinil solution
1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
等级
certified reference material
质量水平
表单
liquid
特点
Snap-N-Spike®/Snap-N-Shoot®
包装
ampule of 1 mL
制造商/商品名称
Cerilliant®
drug control
Új pszichoaktív anyag / New psychoactive substance (Hungary), 78/2022. (XII. 28.) BM rendelet
浓度
1.0 mg/mL in acetonitrile
技术
gas chromatography (GC): suitable
liquid chromatography (LC): suitable
应用
forensics and toxicology
包装形式
single component solution
储存温度
−20°C
SMILES字符串
NC(=O)CS(=O)C(c1ccccc1)c2ccccc2
InChI
1S/C15H15NO2S/c16-14(17)11-19(18)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15H,11H2,(H2,16,17)
InChI key
YFGHCGITMMYXAQ-UHFFFAOYSA-N
基因信息
human ... SLC6A3(6531)
一般描述
An analeptic drug approved by the US FDA for the treatment of narcolepsy, shift work sleep disorder, and excessive daytime sleepiness. This well known nootropic drug, also known as Provigil® or Modavigil®, is often used as a performance-enhancing drug in academics and sports.
其他说明
Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.
法律信息
CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Modavigil is a registered trademark of Cephalon, Inc.
Provigil is a registered trademark of Cephalon, Inc.
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany
警示用语：
Danger
危险分类
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2
储存分类代码
3 - Flammable liquids
WGK
WGK 2
闪点(°F)
35.6 °F - closed cup
闪点(°C)
2 °C - closed cup
法规信息
监管及禁止进口产品
此项目有
Management of cognition and fatigue.
Susan M Rubin
Disease-a-month : DM, 59(7), 269-272 (2013-06-22)
Modafinil, inhibitory control, and alcoholism.
Samuel R Chamberlain
Biological psychiatry, 73(3), 207-208 (2013-01-23)
Luc Laberge et al.
Current neurology and neuroscience reports, 13(4), 340-340 (2013-02-23)
Myotonic dystrophy type 1 (DM1) represents the 1 chronic neuromuscular disease with the most prominent sleep disorders, including excessive daytime sleepiness (EDS), sleep apneas, periodic leg movements during sleep, and rapid eye movement sleep dysregulation. The large majority of DM1
Brigitte Lesur et al.
Chemical biology & drug design, 81(3), 429-432 (2012-11-01)
In search of a next generation molecule to the novel wake-promoting agent modafinil, a series of aryl-heteroayl-derived wakefulness enhancing agents (in rats) was developed. From this work, compound 16 was separated into its enantiomers to profile them individually.
Hypersomnia due to bilateral thalamic lesions: unexpected response to Modafinil.
I Zavalko et al.
European journal of neurology, 19(11), e125-e126 (2012-08-21)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持